CHANGES IN DETERMINANTS OF BLOOD RHEOLOGY DURING TREATMENT WITH HEMODIALYSIS AND RECOMBINANT-HUMAN-ERYTHROPOIETIN

被引:22
作者
KOPPENSTEINER, R
STOCKENHUBER, F
JAHN, C
BALCKE, P
MINAR, E
EHRINGER, H
机构
[1] First Department of Medicine, University of Vienna
来源
BMJ-BRITISH MEDICAL JOURNAL | 1990年 / 300卷 / 6740期
基金
英国医学研究理事会;
关键词
D O I
10.1136/bmj.300.6740.1626
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1626 / 1627
页数:2
相关论文
共 5 条
[1]  
CHIEN S, 1975, RED BLOOD CELL, P2
[2]  
CLAUSS A, 1957, ACTA HAEMATOL, V17, P235
[3]  
HARKNESS J, 1963, LANCET, V2, P280
[4]  
Kiesewetter H, 1983, CLIN HEMORHEOL, V2, P93
[5]   EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT-DNA ON THE ANEMIA OF PATIENTS MAINTAINED BY CHRONIC-HEMODIALYSIS [J].
WINEARLS, CG ;
PIPPARD, MJ ;
DOWNING, MR ;
OLIVER, DO ;
REID, C ;
COTES, PM .
LANCET, 1986, 2 (8517) :1175-1178